Ranibizumab
Indication
Age-related macular degeneration (NICE TA155)
NICE TA155 - Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Red
Brand:
Lucentis®
Nice TA:
155
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Eye